about
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targe...
Read More
2.37
-0.11
(-4.44%)
2.5M
XNAS Volume
XNAS 17 Oct, 2025 5:30 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Moderately Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
C4 Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..